[144] Vita Coco Company, Inc. SEC Filing

Rhea-AI Filing Summary

Vita Coco Company, Inc. (COCO) filing a Form 144 notifies the proposed sale of 3,000 common shares to be sold through Morgan Stanley Smith Barney on 09/16/2025 on NASDAQ. The shares were acquired the same day by exercise of stock options and paid for in cash.

The filing also discloses multiple recent 10b5-1 sales by Corey Baker totaling 7,000 shares across nine trading dates from 09/05/2025 to 09/15/2025 with gross proceeds reported for each sale. The filer certifies no undisclosed material adverse information and includes broker details and share counts but provides no additional context about ownership percentage or intent.

Positive

• Use of a 10b5-1 trading plan is disclosed for recent sales, indicating pre-arranged, compliant insider selling
• Full disclosure of broker, dates, and gross proceeds for recent transactions supports transparency

Negative

• Insider selling activity — proposed sale of 3,000 shares plus 7,000 shares sold recently by Corey Baker could attract investor scrutiny
• No ownership percentage or post-sale holdings disclosed, so impact on insider stake cannot be assessed from this filing

Insights

Financial Analyst

TL;DR Routine insider option exercise followed by proposed and recent 10b5-1 sales; disclosure is informational rather than materially transformative.

The filing documents an immediate exercise of stock options and a contemporaneous proposed sale of 3,000 common shares via Morgan Stanley Smith Barney, plus seven recent 10b5-1 sales by Corey Baker totaling 7,000 shares over early to mid-September 2025. For investors this is a narrow insider liquidity event rather than a corporate operational change. No figures on ownership percentage, dilution impact, or relation to compensation schedules are provided in the filing.

Corporate Governance Expert

TL;DR Disclosure follows required Rule 144 and 10b5-1 protocol; documentation supports compliance but raises routine governance monitoring points.

The submission identifies the broker, execution date, and that the securities were acquired by option exercise and paid in cash. The repeated 10b5-1 sales by an identified individual are properly listed with dates and gross proceeds, indicating use of a pre-arranged trading plan. The filing does not assert any material non-public information and includes the standard attestation language. Governance implications are procedural; no breaches or unusual transactions are evident from the disclosed data alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	119370.00	56822981	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2025	Exercise of Stock Options	Issuer			3000	09/16/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/15/2025	1000	40000.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/12/2025	1000	40000.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/11/2025	1000	38660.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/10/2025	1000	38160.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/09/2025	1000	38400.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/08/2025	1000	38510.00
10b5-1 Sales for COREY BAKER 250 Park Avenue South, 7th Floor New York NY 10003	Common	09/05/2025	1000	38000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many COCO shares are proposed for sale in this Form 144?

The filing proposes the sale of 3,000 common shares on 09/16/2025.

Who is the broker handling the proposed COCO sale?

The broker listed is Morgan Stanley Smith Barney LLC (Executive Financial Services) located at 1 New York Plaza, 8th Floor, New York, NY.

Were the shares to be sold recently acquired or purchased earlier?

According to the filing, the 3,000 shares were acquired on 09/16/2025 by exercise of stock options and paid for in cash the same day.

Has an insider recently sold other COCO shares?

Yes. The filing lists seven recent 10b5-1 sales by Corey Baker totaling 7,000 shares executed between 09/05/2025 and 09/15/2025 with reported gross proceeds per trade.

Does the filing state any undisclosed material information about Vita Coco (COCO)?

No. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.